×
Two For the Road PDF
$ 40.00
Two For the Road PDF quantity
$ 40.00
×
Combining Stimulants and Monoamine Oxidase Inhibitors: A Reexamination of the Literature and a Report of a New Treatment Combination PDF
$ 40.00
Combining Stimulants and Monoamine Oxidase Inhibitors: A Reexamination of the Literature and a Report of a New Treatment Combination PDF quantity
$ 40.00
×
Prevalence of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder Among Substance Abusers. PDF
$ 40.00
Prevalence of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder Among Substance Abusers. PDF quantity
$ 40.00
×
Prevalence of Obsessive-Compulsive Disorder in Patients With Systemic Lupus Erythematosus PDF
$ 40.00
Prevalence of Obsessive-Compulsive Disorder in Patients With Systemic Lupus Erythematosus PDF quantity
$ 40.00
×
Prepregnancy Body Mass Index, Gestational Weight Gain, and the Likelihood of Major Depressive Disorder During Pregnancy PDF
$ 40.00
Prepregnancy Body Mass Index, Gestational Weight Gain, and the Likelihood of Major Depressive Disorder During Pregnancy PDF quantity
$ 40.00
×
Aripiprazole Partial Agonism at 5-HT2C : A Comparison of Weight Gain Associated With Aripiprazole Adjunctive to Antidepressants With High Versus Low Serotonergic Activities PDF
$ 40.00
Aripiprazole Partial Agonism at 5-HT2C: A Comparison of Weight Gain Associated With Aripiprazole Adjunctive to Antidepressants With High Versus Low Serotonergic Activities PDF quantity
$ 40.00
×
The Relationship Between Adverse Childhood Experiences and Symptom Severity, Chronicity, and Comorbidity in Patients With Obsessive-Compulsive Disorder PDF
$ 40.00
The Relationship Between Adverse Childhood Experiences and Symptom Severity, Chronicity, and Comorbidity in Patients With Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Prescribing of Z-Drugs With and Without Opioid Coprescribing to Primary Care Patients in a Large Health Care System From 2019–2020 PDF
$ 40.00
Prescribing of Z-Drugs With and Without Opioid Coprescribing to Primary Care Patients in a Large Health Care System From 2019–2020 PDF quantity
$ 40.00
×
The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues: An Update From the US Food and Drug Administration PDF
$ 40.00
The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues: An Update From the US Food and Drug Administration PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
